(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

IMIDAZOQUINOLINAS SUBSTITUÍDAS COMO AGONISTAS DE TLR7

ArquivadaInvention PatentPCT · EP2018073485
Talk to an expert

Application data

Number

112020004505

Type

Invention Patent

Filing

08/31/2018

Publication

09/15/2020

PCT

EP2018073485
View on INPI

Progress at the INPI

  1. Filing08/31/18
  2. Publication09/15/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/27/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

B. S. (pessoa física)

DE

See this company's full portfolio

Inventors

C. H. (pessoa física)

DE

Technical data

IPC Classification

A61K 31/437A61P 35/00C07D 401/04

Priority claims

EP

PCT/EP2017/072353 · 09/06/2017

Abstract

A invenção se refere a derivados de imidazoquinolina e a composições farmacêuticas contendo os derivados de imidazoquinolina. Os derivados de imidazoquinolina da invenção são úteis como agonistas de receptores do tipo toll, em particular, agonistas de TLR7, e promovem a indução decertas citocinas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

05/27/2025

RPI 2838

Exigência - art. 36 da LPI

#6.1

01/07/2025

RPI 2818

Parecer de pré-exame

#6.23

08/16/2022

RPI 2693

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

09/15/2020

RPI 2593

Alteração de dados cadastrais

#1.1

03/17/2020

RPI 2567

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.